A Phase Ib/II Clinical Study of AK127 in Combination With AK112 in Patients With Advanced Solid Tumors
Clinical trial NCT05951608 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT05951608
- Sponsor
- Akeso
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2023-10-16
- Primary completion
- 2026-05-01
- Enrollment
- 216
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.